Purpose. Mycoplasma ovipneumoniae is a pathogen that causes atypical pneumoniae in sheep and goats. While infection of lambs can induce strong immune responses, typically measured as serum antibodies, experimental vaccines appear to induce lower antibody titres. The purpose of this study was to better understand the bacterium and its interaction with the host, in order to improve the vaccination strategy.
INTRODUCTION
Mycoplasmas are a diverse group of small bacteria that lack a cell wall. The bacteria have a reduced genome with limited biosynthetic capabilities and a dependence on host factors for replication and survival. Which specific factors the bacteria require appears to depend on the mycoplasma species and isolate, as there is considerable variability between and within groups of mycoplasmas [1, 2] .
Many mycoplasmas can adhere to host cells via adhesins and some mycoplasmas can invade host cells, which can help the bacteria evade the host immune response [3] [4] [5] [6] [7] . Many mycoplasmas have also been shown to have a highly variable cell surface, either through antigen variation or phase variation. This heterogeneity can render immune responses to bacterial surface antigens ineffective [1, [8] [9] [10] [11] [12] [13] .
Mycoplasma ovipneumoniae is a pathogen of sheep and goats, but has also been isolated from pneumonic muskox [14] [15] [16] [17] [18] . In sheep, transmission is thought to be from ewes to lambs shortly after birth, and lambs have succumbed to M. ovipneumoniae as young as 6 weeks old in Iceland (Olof G. Sigurdardottir, unpublished data), although these early deaths are uncommon.
The bacteria can cause atypical pneumonia with a nonproductive cough, seen mostly in lambs during summer and fall [19] , but also subclinical -and possibly asymptomaticinfection [20] . It has been suggested that M. ovipneumoniae prevents normal ciliary activity in the host, which facilitates the invasion of the lower respiratory tract by other organisms, such as Mannheimia haemolytica [2, 16] , whose symptoms are mostly seen during fall and winter. Mixed strains of M. ovipneumoniae appear to be more pathogenic in sheep than pure cultures, and multiple strains have been isolated from sheep flocks [19, [21] [22] [23] . Antigenic variation and phase variation have not been studied for M. ovipneumoniae and while the bacteria have been found in phagocytic cells such as macrophages and neutrophils [14] , it is not clear whether they are intracellular pathogens. Vaccination against M. ovipneumoniae is likely to be a cost-effective measure, but while natural infection of lambs can induce strong antibody responses, experimental vaccines appear to require high concentrations of antigen to induce similar antibody titres [18, 24, 25] .
Study of M. ovipneumoniae has been hampered by difficulty in culturing the bacteria and a lack of tools. While multilocus sequence type (MLST) databases exist for many of the other mycoplasmas [26] [27] [28] [29] [30] , suitable targets for generating a complete M. ovipneumoniae MLST database have not yet been described. However, Cassirer et al. described primers for amplification of the genes encoding DNA gyrase subunit B, RNA polymerase subunit beta and 16S, as well as the 16S-23S intergenic region [31] . The availability of draft genomes has enabled genetic analysis of M. ovipneumoniae and availability of commercial culture medium has allowed culture of difficult isolates. In this study, we describe primers for amplifying sequences from seven housekeeping genes that may be suitable for building an MLST database for M. ovipneumoniae. We further characterize Icelandic M. ovipneumoniae isolates, in order to better understand the bacteria and their interaction with their hosts.
METHODS

M. ovipneumoniae cultures
Ovine lung tissue that presented macroscopic signs of pneumonia characteristic of M. ovipneumoniae infection was collected by trained veterinarians between 2009-2016 and stored at À80 C. Tissue samples were incubated and passaged in ML liquid medium (Mycoplasma Experience, UK) at 37 C in a CO 2 enriched environment in Oxoid AnaeroJars (Thermo Fisher Scientific, UK) with Oxoid CampyGen (3.5L) or CO 2 Gen (2.5L) sachets (Thermo Fisher Scientific). Overall, 122 tissue samples were cultured from 122 animals with symptoms of M. ovipneumoniae infection. Approximately 70 % of the cultures grew to sufficient quantities that DNA could be isolated for sequencing. Growing Icelandic M. ovipneumoniae on agar plates has been largely unsuccessful (data not shown).
DNA isolation and sequencing
Genomic DNA was isolated using the QIAamp DNA Mini kit (Qiagen, Germany), according to the manufacturer's protocol. Genes in this study were PCR amplified in a Veriti thermal cycler (Applied Biosystems, USA) using Illustra PureTaq Ready-to-Go PCR beads (GE Healthcare, UK) using primers from TAG Copenhagen (Denmark). PCR products were electrophorized in a 1 % agarose gel (AppliChem, Germany) in a BioRad electrophoresis tank (BioRad, Sweden), and imaged using an InGenius Bio-imaging system (Syngene, UK). PCR products were excised and purified using GeneJET Gel Extraction kit (Thermo Fisher Scientific, Lithuania) and sequenced by GeneWiz Europe (formerly Beckman Coulter Genomics, UK). The same primers were used for amplification and sequencing.
Primer design
For PCR amplification, 30-100 ng of template DNA and 20-40 µM primers were used with Illustra Ready-to-Go beads, according to the manufacturer's instructions.
The 16S rRNA gene was amplified and sequenced using the 8F (5¢-AGAGTTTGATCCTGGCTCAG-3¢) and 1544R (5¢-AGAAAGGAGGTGATCCAGCC-3¢) primers [32] , giving a 1536 bp product. The PCR conditions for amplification were 95 C for 3 min, followed by 35 cycles of 95 C for 45 s, 55 C for 45 s and 72 C for 1 min, and final elongation at 72 C for 5 min.
For the seven housekeeping genes, primers were designed using Primer3 (http://biotools.umassmed.edu/bioapps/ primer3_www.cgi), based on the Mycoplasma ovipneumoniae NM2010 reference genome sequence (accession NCBI Reference Sequence: NZ_JAKV00000000.1). These primers are termed 'outer' primers ( Table 1 ). The outer primers were used to amplify and sequence 0.9-4.4 kb segments of the housekeeping genes from 25 Icelandic M. ovipneumoniae isolates. The Icelandic sequences were aligned in Sequencher 5.4.1 (Gene Codes, USA) to the foreign reference genome sequence to find regions that were conserved in all isolates and the reference strain. We generated primers in these regions ('inner' primers, Table 1 ) and propose these primers for building a MLST database for M. ovipneumoniae. Sequences from the Icelandic isolates in this study can be accessed as a ClustalX2 alignment data file (doi:10.17632/kz6v6hp3zg.1).
The 'inner' gene segments were amplified using touchdown PCR. The samples were denatured at 94 C for 2 min, after which 15 cycles were performed consisting of denaturation (94 C for 30 s), annealing (55 C for the first cycle, and decreasing by 0.5 C each cycle, for 30 s) and elongation (72 C for 1 min). Then, 25 additional cycles were performed, where the annealing temperature was 48 C. Lastly, the final elongation step was performed at 72 C for 5 min.
Vaccination of sheep
Four M. ovipneumoniae isolates (designated 1, 11, 15 and 45) were cultured, as described above. Bacteria were pelleted and washed three times with PBS (Sigma-Aldrich, Germany). The bacteria were mixed in equal amounts and inactivated with 1 % formalin at 37 C for 24 h, which was confirmed by inoculating media with inactivated bacteria. The protein concentration was measured using a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, USA).
Overall, 5 mg per milliliter Quil-A (InvivoGen, USA) was added and the bacterin was incubated for 1 h at 37 C. The following day, alhydrogel 2 % (InvivoGen, USA) was added at 25 % vol of the vaccine. The solution was mixed thoroughly and the vaccine administered, approximately 250 µg protein in 0.5 ml per sheep.
Ten 16-month-old sheep were randomly divided into the vaccine and mock-vaccine groups. The sheep were vaccinated four times by subcutaneous injection in the axilla, behind the armpit, over the course of 44 weeks. Blood was drawn prior to vaccination and at pre-defined time-points ( Fig. 1 ). Slight swelling was observed at the injection site in one mock-vaccinated animal during the first week after vaccination, but otherwise no adverse effects were observed following vaccination or during the course of the experiment.
Isolation of peripheral blood mononuclear cells (PBMC)
Sheep blood was drawn into Vacuette 9 ml lithium heparin coated tubes (Greiner bio-one, Austria). The blood was diluted in half in sterile PBS, layered on Histopaque-1077 (Sigma-Aldrich, UK) and spun at 1000 g for 30 min at room temperature (RT). Cells were transferred to new tubes and washed with PBS. The cells were first spun at 913 g for 15 min at RT, and then washed twice again and spun at 340 g for 15 min at RT. When required, cells were treated with red blood cell lysis buffer (0.14M NH 4 Cl+0.02M Tris) for 2 min. Cells were then washed and spun at 228 g for 15 min at RT. Cells were resuspended in lamb serum (collected from abattoir) and 10 % DMSO (Sigma-Aldrich, Germany), transferred to cryovials and stored at À20 C.
Serum and ELISA
Sheep blood was drawn into Vacuette 9 ml serum clot activator coated tubes (Greiner bio-one). Tubes were incubated for 2 h at 37 C and then spun at 913 g for 20 min at RT. Serum was collected into cryovials and stored at À20 C.
Serum was sent to the Animal and Plant Health Agency in the UK for analysis of anti-mycoplasma antibodies using ELISA, as previously published [14] . Sera from the first two vaccinations were assayed together, while sera from the fourth vaccination were measured at a later time-point. In both cases, the positive control serum (historical positive 
rpoB inner 5¢-GATTTTTCAAAAGCCCGTAAAA-3¢ 5¢-CAATTTGAGGTTCGGGATGT-3¢ serum from infected sheep, 318 1/8/08) was set to OD 1.0 and the negative control serum (historical negative serum, 05V0071) to OD 0.1. The PBMC were thawed and washed once with complete medium before plating, as described above. For the data shown in Fig. 5(b) , the PBMC were isolated 2 weeks post vaccination from sheep that had received a total of four vaccinations.
Fetal ovine synovial (FOS) and PBMC cultures and in vitro infection
The cells were infected for 24 h (when examining bacterial location, see pre-staining of bacteria in EZ-Link Sulfo-NHSBiotin staining) or 8 days (when examining cellular proliferation) with a newly isolated mixed culture of M. ovipneumoniae (approximately 1.5-2 mg ml À1 ; 10 µl/96 well and 100 µl/24 well). Newly isolated bacteria were used to decrease the risk of bacterial attenuation due to extended culture. The infected cells were incubated in anaerobic jars, as described above, or in a 5 % CO 2 incubator. These experiments were repeated three times with 4-7 replicates per sample in anaerobic jars and once in a CO 2 incubator.
When examining bacterial location, cells were infected with M. ovipneumoniae, Escherichia coli DH5a (extracellular bacterium) or Bacille Calmette Guerin (BCG, intracellular bacterium), or were left uninfected. After 24 h, the cells were treated with 100 µg ml À1 gentamicin (Gibco, USA) for 4 h at 37 C and 20 µg ml À1 µM proteinase K (New England Biolabs, USA) for 30 min at 37 C to remove extracellular bacteria, or were left untreated. Cells were then washed and resuspended in PBS (for intact cells) or water (for disrupted cells). Cells were then transferred to Starfrost microscope slides (Knittel Glass, Germany) and fixed with 10 % formalin for 10 min. Cells were then washed three times with 0.05 % PBS-tween 20 (Sigma-Aldrich, France) and stained with 1.5 µg streptavidin DyLight 488 or 650 conjugate (Thermo Fisher Scientific, USA) for 2 h. Cells were then washed three times with 0.05 % PBS-tween 20 and examined in a DM LB microscope (Leica, USA).
When examining cellular proliferation, cells were either counted based on trypan blue exclusion (data shown in Fig. 5b ) or the amount of DNA measured in each well with a spectrometer (data not shown). For DNA measurements, the cells were washed once with PBS before addition of 50 µl 10 % formalin and incubated at 4 C overnight before measuring DNA quantity in the wells using a NanoDrop ND-1000 spectrophotometer.
EZ-Link Sulfo-NHS-Biotin staining M. ovipneumoniae, E. coli DH5a and BCG bacterial cultures were washed twice with PBS and spun at 340 g for 20 min at 4 C before being stained with EZ-Link Sulfo-NHS-Biotin (Thermo Fisher Scientific, USA), according to the manufacturer´s protocol. Stained and mock-stained bacteria were resuspended in complete medium and immediately used to infect cells. Bacteria were visualized after infection by staining with streptavidin DyLight 488 or 650 conjugate. Bacteria that were unlabelled, or were incompletely labelled with only one component (either EZ-Link Sulfo-NHS-Biotin or streptavidin-DyLight) were not fluorescent (data not shown).
Statistical analysis and graphics
Sequence data was aligned using Sequencher and graphed using ClustalX2 [33] and MEGA 6.06 [34] or DARwin 6.0.14 (http://darwin.cirad.fr/).
Distance trees were constructed using the neighbour-joining algorithm in MEGA (single genes) or DARwin (head-to-tail compilations) with 500 bootstraps; the number on each node indicates the percentage with which each topology branch was supported.
Dissimilarity values were calculated in DARwin with no gaps or missing data. There were 34 sequences of head-totail data (3932 bp).
GraphPad Prism 6.07 (GraphPad, USA) was used to graph ELISA and cell proliferation data, as well as statistical analysis using the D'Agostino and Pearson omnibus normality test, a two-tailed t-test, one-way ANOVA and repeated measures two-way ANOVA. A P-value<0.05 was considered statistically significant.
RESULTS
16S rRNA analysis
Altogether, 39 M. ovipneumoniae isolates were mixed cultures and were excluded from this study. However, 47 isolates were sufficiently pure for analysis of the 16S rRNA gene (Fig. 2) . Comparison of the sequences indicates that these bacteria fall into four groups. No identifiable geographical pattern to the distribution of the groups was observed (Fig. 3) . In general, analysis of one bacterial isolate per farm is depicted. The exception is one region where sampling of two adjacent farms resulted in recovery of 12 isolates from 12 animals (isolates 3, 8, 10, 12, 13, 17, 22, 23, 27, 28, 33 and 39).
Variability of housekeeping genes
To further examine the genetic variability of the isolates, we examined seven housekeeping genes; ATP synthase subunit alpha 2 (atpA), heat shock protein 70 (dnak), glutamatetRNA synthetase (gltX), DNA gyrase subunit B (gyrB), RNA polymerase subunit beta (rpoB), triosephosphate isomerase (tpiA) and elongation factor Tu (tuf).
Analysis of the housekeeping genes revealed that some isolates that had appeared to be single colony isolates by 16S analysis were mixed cultures. These samples were excluded, leaving 34 isolates for further analysis.
The variability of each of the seven genes is shown in dendrograms (Fig. S1 , available in the online version of this article), drawn in MEGA, as well as a compilation of the seven genes head-to-tail (3932 bp), drawn in DARwin (Fig. 4) . The dissimilarity value of the 34 head-to-tail data ranged from 0.00102 to 0.03001. Analysis of clades and the index of association requires additional and more diverse data.
The data show little correlation between the 16S and headto-tail housekeeping gene dendrograms. There is also little correlation between the different housekeeping genes, whether the nucleotide sequences were compared (Fig. S1) or the amino acid sequences (data not shown). More samples are needed to further analyse this.
Humoral responses
Six sheep were vaccinated with a mixture of four M. ovipneumoniae isolates (isolates 1, 11, 15 and 45 from Fig. 2 ). The isolates came from two branches of the 16S tree. Four sheep were mock-vaccinated with PBS in adjuvant. The sheep were vaccinated four times over a period of 10 months, and blood samples were drawn for serum analysis and/or isolation of PBMC (Fig. 1) .
The antibody response to the vaccine was modest, and did not appear to be greatly increased by boosting the sheep (Fig. 5a , comparison of 9 weeks post vaccination (wpv) data point to the weeks post first boost (wpfb) data points). A repeated measures two-way ANOVA indicated that there was a significant difference between the vaccinated and mock-vaccinated groups (P<0.01). After the first vaccination, the antibody response was significantly higher in the vaccinated group 6 weeks post-vaccination (two-tailed ttest, P<0.001), but the importance of this difference is questionable as the vaccinated group had significantly higher anti-mycoplasma antibodies prior to vaccination than the control group (two-tailed t-test, P<0.01).
After the fourth vaccination, the antibody responses in the vaccinated group were significantly higher than in the control group (two-tailed t-test, P<0.001 at 2, 3 and 4 weeks post boost and P<0.05 at 6 weeks post boost). Again, the importance of this difference is questionable, since the antibody titre is lower than it was from previous vaccinations. It is possible that the difference stems from the sera collected after the fourth vaccination being assayed at a later timepoint than sera collected after the first two vaccinations, although the sera from mock-vaccinated sheep were not significantly different between vaccination groups (repeated measures, two-way ANOVA).
One of the vaccinated sheep did not respond to the vaccination, but the results were still not significant when this sheep was excluded from the analysis (data not shown).
The data indicate that the animals may have been previously exposed to M. ovipneumoniae and are likely to have been exposed again during the trial period, although antibody spikes caused by other infections cannot be ruled out. 
Analysis of M. ovipneumoniae location
It is not clear whether the bacteria are able to infect and remain intracellular in cells other than macrophages and neutrophils, or whether the infection is strictly extracellular. To examine this, we infected ovine PBMC and FOS cells for 24 h with bacteria that had been labelled with a biotinlinked dye that binds proteins (Sulfo-NHS-Biotin) or CFSE. We also infected cells with labelled E. coli (extracellular bacteria) or BCG (intracellular bacteria) as controls (Fig. S2) . A subset of wells received treatment with gentamicin and proteinase K to remove bacteria adhering to the cell surface. Cells were subsequently ruptured with osmotic pressure or left intact. Sulfo-NHS-Biotin-labelled bacteria were then stained with a streptavidin-DyLight conjugate to visualize the bacteria.
Results indicate that M. ovipneumoniae can be found both extracellularly, bound to the target cells in clumps (Fig. 6a,  b) , and intracellularly. Gentamicin and proteinase K are able to remove these extracellular bacteria (Fig. 6c, d) , and the streptavidin-conjugate is unable to stain the bacteria residing within the cells, unless the cells are ruptured (Fig. 6e, f) . The bacteria appear to have a wider distribution inside the cells, i.e. there were multiple bacterial foci inside the cells while there was generally a single focus on the cellular surface. A similar distribution pattern was seen when the bacteria were labelled with CFSE (data not shown), which suggests that the Sulfo-NHS-Biotin labelling does not alter the infectivity and distribution of the bacteria. There were rare occurrences of E. coli staining after gentamicin and protease K treatment followed by osmotic rupture (data not shown). This could be due to incomplete clearance of extracellular bacteria or bacterial phagocytosis. As the cells are ruptured by osmotic pressure, unbiased quantification of intracellular and extracellular bacteria is difficult. Furthermore, it is unclear whether the bacteria are localized to specific organelles or locations and whether they are viable.
The results indicate that the bacteria may reside intracellularly in non-professional antigen-presenting cells during infection and that measuring antibody responses may be insufficient to describe the immune response to M. ovipneumoniae. For this reason, we next examined the cellular responses to the bacterium. 
Cellular responses
PBMC from vaccinated and mock-vaccinated sheep were cultured with M. ovipneumoniae isolates and cellular proliferation was examined. The 16S genes were sequenced to confirm that the cultures were not contaminated prior to use in the assay. The experiment was performed several times, and while we sometimes got proliferation in pilot studies, the majority of experiments gave limited cellular proliferation (data not shown).
No significant difference in cell numbers was observed when we compared PBMC cultured with live M. ovipneumoniae or heat-killed bacteria (data not shown). Staining of the cells with anti-CD4 or anti-CD8 antibodies indicated that CD4 and CD8 T cells were present, as well as other cell Fig. 4 . Phylogenetic relationship of 34 Icelandic ovine M. ovipneumoniae isolates, based on 3932 bp head-to-tail compilations of seven housekeeping genes. The tree was generated in DARwin with no gaps or missing data using the neighbour-joining algorithm. Bootstrap values shown at the nodes are derived from 500 replicates and branch lengths corresponding to the divergence of sequences are indicated by the relative scale (scale bar). Colour coding of the isolates is according to the 16S branches shown in Fig. 2. types, but their numbers did not increase detectably upon exposure to bacteria (data not shown).
As the M. ovipneumoniae isolates used in this study were shown to have variation in conserved genes, i.e. the 16S and housekeeping genes (Figs 2 and S1 ), it is likely that there is a high degree of variation in other genes as well. We therefore cultured PBMC from the six vaccinated sheep and four mockvaccinated sheep with one of six different M. ovipneumoniae isolates or concanavalin A (ConA) for 8 days and counted the cells or measured the amount of DNA in each well (Fig. 5b  and data not shown) . One of the isolates used to stimulate the cells was included in the vaccine (isolate 1, shown in black). Measurement of DNA and counting based on trypan blue exclusion produced similar results, which indicates that DNA The data show average fold increase in the number of stimulated cells over unstimulated cells. The cells proliferated and were viable, as indicated by trypan blue exclusion. However, the response was moderate and proliferation induced by the vaccine isolate was not significantly greater in the vaccinated group than in the mock-vaccinated group (two-tailed t-test).
DISCUSSION AND CONCLUSIONS
Iceland is divided into 26 quarantine zones for ruminants to prevent the spread of sheep and goat diseases such as Johne's disease and scrapie [35] [36] [37] . While there have been incidents where animals have crossed zones and animals have been sold from 'disease-free' zones to other zones, the overall contact of animals between regions is limited. For this reason, we expected to find geographically distinct populations of M. ovipneumoniae in Iceland. However, while the small sample size limits interpretation of the data, the different 16S groups appear to be spread across the country regardless of quarantine zones. Comparison of seven housekeeping gene sequences revealed a pattern of variation that is inconsistent between the different housekeeping genes. Some mycoplasmas have little polymorphism, such as M. pneumoniae, whose homogeneity made development of an MLST scheme difficult [29] . Others are very diverse, such as M. hyopneumoniae [28] . The data in this study indicate that the genetic diversity of M. ovipneumoniae is fairly high. This makes whole genome sequencing of Icelandic M. ovipneumoniae difficult, since isolation of single colony isolates on agar is extremely difficult. However, the housekeeping gene sequences can add significant information over 16S data alone.
Bacterial staining indicates that M. ovipneumoniae is likely an intracellular pathogen, although the cellular location and viability of the bacteria remain to be established. Vaccines that induce both humoral and cellular responses are likely to be beneficial in fighting the infection. Several companies offer autogenous vaccines of M. ovipneumoniae, which are often combined with other inactivated bacteria, e.g. Mannheimia haemolytica, although there is limited scientific data on the effectiveness of these vaccines. Four vaccinations with bacterin did not induce humoral or cellular responses of the expected magnitude in this study, which suggests that repeated vaccination may not be beneficial. However, the results are complicated by the fact that the sheep were likely exposed to mycoplasma before and during the study. While this may affect the induction of immune responses by the vaccine, lambs in endemic regions are likely to be exposed to mycoplasma soon after birth and repeatedly during their lives. The data are supported by the findings of Ziegler et al. [24] . who saw dramatically reduced induction of antibodies in sheep that had prior exposure to M. ovipneumoniae compared to animals that were naive. Exposure to virulent bacteria and bacterin vaccination with rapidly growing isolates [25] appear to induce stronger immune responses and may confer improved protection. Alternatively, a recombinant vaccine may overcome the hindrance of pre-existing anti-mycobacterial immune responses by eliciting an immune response to novel targets, such as intracellular proteins. One of the seven housekeeping genes studied, elongation factor Tu, which is coded by tuf, showed no variation in amino acid sequence between the 34 isolates and Zhang et al. showed that the protein was immunogenic in mice [38] . Together, these data indicate that elongation factor Tu may be a possible vaccine candidate.
While there are limited immunological tools available for sheep, in this study we were able to reliably label M. ovipneumoniae using a protein dye. This allows the possibility of expanding the tools for studying the bacteria, e.g. using flow cytometry and targeting molecules to M. ovipneumoniae by linking them to streptavidin, as well as experimental infection of lambs with labelled bacteria to elucidate hostbacterial interactions throughout infection. While sheep farming and health is important in Iceland, it is relatively small on a global scale compared to other livestock. However, the tools described here are also applicable to other mycoplasmas, such as other economically important veterinary mycoplasmas and human pathogens. 
